CAR T-Cell Therapy Cost Effectiveness
Chimeric Antigen Receptor (CAR) T cell therapy is an immunotherapy that uses genetically modified T cells to target and kill cancer cells. The treatment has shown promising results in clinical trials for various types of cancer, including large B cell lymphoma (58% success rate) and multiple myeloma (60% accordingly). The estimated cost of CAR T-cell treatment starts from $55,000 to $450,000 per infusion. The total prices vary by country: USA from $370,000; UK from $130,000; China from $55...
275
2